Novozymes is a biotech-based company, headquartered in Denmark and employing approximately 6,000 people in 30 countries. Innovation and sustainability are core to Novozymes’ business values and objectives.
Europe’s push for strategic autonomy will rise or fall on how work is organised. Beyond factories, chips and critical raw materials, the decisive question is whether our workplaces can learn faster, innovate continuously, and deliver both productivity and quality jobs. That is the promise of workplace innovation—and why it belongs at the centre of Industry 5.0.
Will the share of monotonous, repetitive jobs decrease, or will new ones be created? Will there be fewer dangerous jobs, or will new dangerous tasks emerge? Will algorithmic management of workers lead to greater efficiency, or will it also bring permanent surveillance and privacy problems? And so on.
Funded by the European Union under grant agreement No 101069651. The contents of this publication are however the sole responsibility of the BRIDGES 5.0 project consortium only and do not necessarily reflect those of the European Union or HADEA. Neither the European Union nor HADEA can be held responsible for them.
In Partnership with
© 2026 • Industry 5.0 is created and managed by Workplace Innovation Europe and part of the Bridges 5.0 Project.